ciprofloxacin has been researched along with pentoxifylline in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boegel, F; Getty, L; Jennings, LW; Meyer, W; Nemunaitis, J; Rosenfeld, C; Shadduck, R; Zeigler, Z | 1 |
| Benyunes, MC; Bianco, JA; Fefer, A; Neubauer, MA; Slattery, JT; Thompson, JA | 1 |
| Benyunes, MC; Bianco, JA; Fefer, A; Thompson, JA | 1 |
| Berlanga, JJ; Brunet, S; de Sanjosé, S; Ferrà, C; Gallardo, D; García, J; Grañena, A; Lastra, CF; Mariño, EL; Martí, F; Sureda, A | 1 |
| Dar, S; Qawi, H; Raza, A; Reza, S; Shetty, V | 1 |
| Andrews, C; Andric, T; Dar, S; Gezer, S; Gregory, S; Hsu, WT; Huang, RW; Lisak, L; Loew, J; Qawi, H; Raza, A; Rifkin, S; Robin, E; Venugopal, P | 1 |
| Gong, Y; Johnson, J; Kneteman, N; Minuk, GY; Moser, M; Zhang, M | 1 |
| du Toit, C; Finlayson, J; Mohamed, R; Novitzky, N | 1 |
| Chang, WH; Chen, LT; Hong, RC; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Blanchard, MG; Gonzalez, FJ; Peterson, MR; Peterson, TC; Wornell, PA | 1 |
| Bensinger, WI; Buckner, CD; Holmberg, L; Lilleby, K; Slattery, JT; Storb, R | 1 |
| Bergstrand, IC; Björkman, S; Heijl, A; Höglund, P; Magnusson, M; Roth, B | 1 |
| Bae, SH; Cho, HS; Hyun, MS; Kim, MK; Lee, JL; Lee, KH; Ryoo, HM | 1 |
| Peterson, MR; Peterson, TC; Raoul, JM | 1 |
| Bilgi, O; Erikci, AA; Kandemir, EG; Karagoz, B; Ozturk, A; Top, C; Turken, O | 1 |
| Chatel, C; Delanian, S; Depondt, J; Lefaix, JL; Porcher, R | 1 |
| Pshenkina, NN | 1 |
2 review(s) available for ciprofloxacin and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells.
Topics: Carcinoma, Renal Cell; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Immunotherapy, Adoptive; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Pentoxifylline; Recombinant Proteins | 1993 |
8 trial(s) available for ciprofloxacin and pentoxifylline
| Article | Year |
|---|---|
Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial.
Topics: Adult; Aged; Ciprofloxacin; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Hematopoietic Stem Cells; Humans; Interleukin-6; Male; Middle Aged; Myelodysplastic Syndromes; Pentoxifylline; Tumor Necrosis Factor-alpha | 1995 |
Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Ciprofloxacin; Female; Humans; Immunotherapy, Adoptive; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Male; Middle Aged; Pentoxifylline | 1994 |
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Topics: Adolescent; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Pentoxifylline; Prednisone; Prospective Studies; Stomatitis; Treatment Failure; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1997 |
Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Biopsy; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; Hematologic Tests; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes; Pentoxifylline; Tumor Necrosis Factor-alpha | 1998 |
Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Ciprofloxacin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Pentoxifylline; Transplantation, Autologous; Transplantation, Isogeneic | 2004 |
A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans.
Topics: Adult; Blood Flow Velocity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Enzyme Inhibitors; Epidemiologic Methods; Female; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Pentoxifylline; Retinal Vessels; Rifampin; Vasodilator Agents | 2006 |
The hematologic response to anti-apoptotic cytokine therapy: results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Apoptosis; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Erythrocyte Count; Female; Hematologic Agents; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Pentoxifylline; Platelet Count; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Ciprofloxacin; Clodronic Acid; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Pentoxifylline; Prednisone; Prognosis; Tocopherols | 2011 |
13 other study(ies) available for ciprofloxacin and pentoxifylline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Ciprofloxacin; Dexamethasone; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypotension; Male; Middle Aged; Myelodysplastic Syndromes; Palliative Care; Pentoxifylline; Treatment Outcome | 2000 |
Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis.
Topics: Animals; Anti-Infective Agents; Aspartate Aminotransferases; Bilirubin; Ciprofloxacin; Diagnosis, Computer-Assisted; Fibrosis; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Medicine, Chinese Traditional; Pentoxifylline; Phosphodiesterase Inhibitors; Preoperative Care; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Survival Analysis; Thymidine | 2000 |
Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.
Topics: Anti-Inflammatory Agents; Antigens, CD34; Apoptosis; Blood Transfusion; Bone Marrow Cells; Cell Division; Ciprofloxacin; Dexamethasone; Glucocorticoids; Humans; In Situ Nick-End Labeling; Leukocyte Count; Myelodysplastic Syndromes; Pentoxifylline; Stem Cells; Stromal Cells | 2000 |
Effect of anti-inflammatory medication on monocyte response to titanium particles.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Ciprofloxacin; Cytokines; Dinoprostone; Enzyme Inhibitors; Humans; Indomethacin; Interleukin-1; Interleukin-6; Materials Testing; Monocytes; Particle Size; Pentoxifylline; Titanium; Tumor Necrosis Factor-alpha | 2000 |
Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.
Topics: Animals; Anti-Infective Agents; Blotting, Western; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Drug Interactions; Enzyme Inhibitors; Liver; Male; Mice; Mice, Knockout; Pentoxifylline; Pertussis Toxin | 2004 |
A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of pentoxifylline.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Half-Life; Injections, Intraperitoneal; Kinetics; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Pentoxifylline; Phosphodiesterase Inhibitors; Stereoisomerism; Time Factors | 2007 |
Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dexamethasone; Female; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Pentoxifylline; Retrospective Studies; Treatment Outcome | 2008 |
[Influence of perftoran on pharmacokinetics of hydrophilic drugs].
Topics: Animals; Blood Substitutes; Cefazolin; Cefotaxime; Ciprofloxacin; Drug Interactions; Fluorocarbons; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Male; Pentoxifylline; Rabbits | 2011 |